Sarah Goring

944 total citations
37 papers, 613 citations indexed

About

Sarah Goring is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sarah Goring has authored 37 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 6 papers in Surgery. Recurrent topics in Sarah Goring's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Statistical Methods in Clinical Trials (5 papers). Sarah Goring is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Statistical Methods in Clinical Trials (5 papers). Sarah Goring collaborates with scholars based in United States, United Kingdom and Canada. Sarah Goring's co-authors include Ellen Korol, Adrian R. Levy, Pat G. Camp, N. Varol, Frank Griesinger, Sheena Kayaniyil, R. Townsend, A H Barnett, Kerstin Müller and Ian Wood and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Sarah Goring

34 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Goring United States 15 165 154 114 104 93 37 613
Josephina G. Kuiper Netherlands 13 110 0.7× 182 1.2× 154 1.4× 63 0.6× 54 0.6× 37 640
Sophie Beale United Kingdom 17 103 0.6× 125 0.8× 286 2.5× 172 1.7× 209 2.2× 42 911
J Oyee United Kingdom 17 205 1.2× 266 1.7× 53 0.5× 100 1.0× 109 1.2× 38 887
Elvira D’Andrea United States 22 79 0.5× 155 1.0× 177 1.6× 145 1.4× 212 2.3× 62 1.1k
Elizabeth M. Garry United States 14 111 0.7× 34 0.2× 113 1.0× 64 0.6× 153 1.6× 32 614
Mona Aeysha Khalid United Kingdom 13 428 2.6× 61 0.4× 88 0.8× 164 1.6× 66 0.7× 28 1.0k
Hayley Bennett United Kingdom 16 152 0.9× 93 0.6× 152 1.3× 76 0.7× 77 0.8× 52 680
Érick Moyneur United States 16 139 0.8× 242 1.6× 501 4.4× 117 1.1× 87 0.9× 43 1.2k
Anja Schiel Norway 13 89 0.5× 35 0.2× 99 0.9× 150 1.4× 124 1.3× 24 582
David D. Yang United States 16 407 2.5× 183 1.2× 59 0.5× 77 0.7× 45 0.5× 61 741

Countries citing papers authored by Sarah Goring

Since Specialization
Citations

This map shows the geographic impact of Sarah Goring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Goring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Goring more than expected).

Fields of papers citing papers by Sarah Goring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Goring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Goring. The network helps show where Sarah Goring may publish in the future.

Co-authorship network of co-authors of Sarah Goring

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Goring. A scholar is included among the top collaborators of Sarah Goring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Goring. Sarah Goring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, Jürgen, Sarah Goring, Adam Lee, et al.. (2025). Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC. Cancers. 17(5). 748–748.
2.
3.
4.
5.
Goring, Sarah, N. Varol, Nathalie Waser, et al.. (2022). Correlations between objective response rate and survival-based endpoints in first-line advanced non-small cell lung Cancer: A systematic review and meta-analysis. Lung Cancer. 170. 122–132. 7 indexed citations
6.
7.
8.
Goring, Sarah, Keith Chan, Shannon Cope, et al.. (2019). PCN440 NETWORK META-ANALYSIS USING FRACTIONAL POLYNOMIALS: HEURISTIC FOR MODEL SELECTION INCORPORATING BEYOND-TRIAL EXTRAPOLATIONS (A MELANOMA EXAMPLE). Value in Health. 22. S521–S521. 1 indexed citations
9.
Tao, Ran, et al.. (2019). A Comparison of National Guidelines for Network Meta-Analysis. Value in Health. 22(10). 1178–1186. 23 indexed citations
10.
Griesinger, Frank, et al.. (2019). Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis. Lung Cancer. 135. 196–204. 88 indexed citations
11.
Varol, N., Nathalie Waser, Juliette C. Thompson, et al.. (2018). PCN56 - TREATMENT EFFECT MODIFICATION (EM) OF ANTICANCER THERAPIES IN FIRST-LINE ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC): A SYSTEMATIC ASSESSMENT OF TRIAL DATA. Value in Health. 21. S23–S23. 1 indexed citations
12.
Lozano‐Ortega, Greta, Nathalie Waser, Mark Bensink, et al.. (2018). Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis. Journal of Comparative Effectiveness Research. 7(7). 693–707. 9 indexed citations
13.
Goring, Sarah, et al.. (2018). The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study. BMC Health Services Research. 18(1). 700–700. 23 indexed citations
14.
Hess, Lisa M., Edward S. Kim, Benjamin Levy, et al.. (2018). Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy. Patient. 12(2). 223–233. 26 indexed citations
15.
Goring, Sarah, et al.. (2016). Inclusion of real-world evidence in submission packages to health technology assessment bodies: What do current guidelines indicate?. Value in Health. 19(3). A287–A287. 3 indexed citations
16.
Goring, Sarah, et al.. (2016). USE OF DISCRETE CHOICE EXPERIMENTS DESIGNED WITH A SINGLE SCENARIO AND TWO OR MORE CHOICES: A SYSTEMATIC REVIEW. Value in Health. 19(3). A92–A92. 1 indexed citations
17.
Lozano‐Ortega, Greta, et al.. (2015). Network meta-analysis of treatments for type 2 diabetes mellitus following failure with metformin plus sulfonylurea. Current Medical Research and Opinion. 32(5). 807–816. 35 indexed citations
18.
Goring, Sarah, Adrian R. Levy, Isabella Ghement, et al.. (2014). A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients. Current Medical Research and Opinion. 30(8). 1473–1487. 17 indexed citations
19.
Camp, Pat G. & Sarah Goring. (2007). Gender and the Diagnosis, Management, and Surveillance of Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society. 4(8). 686–691. 44 indexed citations
20.
Goring, Sarah, et al.. (1990). Group Work with Sex Offenders– the Legal Problems. 12(3). 193–203.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josephina G. Kuiper Breakdown of academic impact, for papers by Sophie Beale Breakdown of academic impact, for papers by J Oyee Breakdown of academic impact, for papers by Elvira D’Andrea Breakdown of academic impact, for papers by Elizabeth M. Garry Breakdown of academic impact, for papers by Mona Aeysha Khalid Breakdown of academic impact, for papers by Hayley Bennett Breakdown of academic impact, for papers by Érick Moyneur Breakdown of academic impact, for papers by Anja Schiel Breakdown of academic impact, for papers by David D. Yang
Rankless by CCL
2026